financetom
Business
financetom
/
Business
/
Cboe Global Markets' Q4 Adjusted Earnings, Revenue Rise; Provides 2025 Revenue Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cboe Global Markets' Q4 Adjusted Earnings, Revenue Rise; Provides 2025 Revenue Guidance
Feb 7, 2025 5:13 AM

07:46 AM EST, 02/07/2025 (MT Newswires) -- Cboe Global Markets ( CBOE ) reported Q4 adjusted earnings Friday of $2.10 per diluted share, up from $2.06 a year earlier.

Analysts polled by FactSet expected $2.13.

Revenue less cost of revenue for the quarter ended Dec. 31 was $524.5 million, compared with $499 million a year earlier.

Analysts surveyed by FactSet expected $525.6 million.

The company said it expects 2025 organic total net revenue growth to be in the mid-single-digit range. Analysts polled by FactSet expect $2.17 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kymera Therapeutics Q3 Loss Widens, Revenue Falls
Kymera Therapeutics Q3 Loss Widens, Revenue Falls
Nov 4, 2025
07:41 AM EST, 11/04/2025 (MT Newswires) -- Kymera Therapeutics ( KYMR ) reported a Q3 net loss Tuesday of $0.94 per diluted share, widening from a loss of $0.82 a year earlier. Analysts polled by FactSet expected a loss of $0.68. Collaboration revenue for the quarter ended Sept. 30 was $2.8 million, compared with $3.7 million a year earlier. As...
Cruise and expeditions organizer Lindblad's Q3 revenue beats estimates
Cruise and expeditions organizer Lindblad's Q3 revenue beats estimates
Nov 4, 2025
Overview * Lindblad Q3 revenue rises 17% to $240.2 mln, driven by strong segment growth * Adjusted EBITDA for Q3 beats estimates, rising 25% to $57.3 mln * Company refinances long-term debt, lowering interest rate to 7% and extending maturity to 2030 Outlook * Company expects full-year 2025 tour revenues of $745 mln to $760 mln * Lindblad projects 2025...
Verastem Oncology Q3 revenue hits $11.2 mln, net loss widens
Verastem Oncology Q3 revenue hits $11.2 mln, net loss widens
Nov 4, 2025
Overview * Verastem Q3 2025 net product revenue reaches $11.2 mln, marking successful product launch * Company reports Q3 net loss of $98.5 mln, reflecting increased operating expenses * VS-7375 trial shows promising preliminary results in KRAS G12D mutant solid tumors Outlook * Verastem ( VSTM ) expects cash runway into the second half of 2026 * Company plans to...
Integral Ad Science Q3 revenue beats estimates
Integral Ad Science Q3 revenue beats estimates
Nov 4, 2025
Overview * IAS Q3 revenue grows 16% yr/yr to $154.4 mln, beating analyst expectations * Adjusted EBITDA for Q3 beats estimates, increasing to $55.3 mln * IAS in process of being bought by acquisition PE firm Novacap Outlook * IAS will not provide a financial outlook due to pending acquisition by Novacap Result Drivers * OPTIMIZATION REVENUE - Optimization revenue...
Copyright 2023-2026 - www.financetom.com All Rights Reserved